Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clarence R Hurt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|October 25, 2001
Enantiospecific Synthesis of (R)-4-Amino-5-oxo-1,3,4,5-tetrahydrobenz[cd]indole, an Advanced Intermediate Containing the Tricyclic Core of the ErgotsClarence R. Hurt, Ronghui Lin, Henry Rapoport
Current Pharmaceutical Biotechnology|March 21, 2012
Capsid assembly as a point of intervention for novel anti-viral therapeuticsVishwanath R Lingappa, Clarence R Hurt, Edward Garvey
Critical Reviews in Immunology|January 3, 2021
A Common Druggable Defect in Regulatory T Cells from Patients with AutoimmunityLuis Soares, Linda Yip, Clarence R Hurt, et al.
Molecular Diversity|March 4, 2009
Combinatorial chemistry: oh what a decade or two can doWalter H Moos, Clarence R Hurt, Guillermo A Morales
Journal of Virological Methods|June 15, 2013
Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitorsKevin B Spurgers, Clarence R Hurt, Jeffrey W Cohen, et al.
Frontiers in Immunology|December 26, 2022
How GRAIL controls Treg function to maintain self-toleranceC Garrison Fathman, Linda Yip, Diana Gómez-Martín, et al.
Journal of Virology|November 5, 2020
Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 AssemblyJonathan C Reed, Dennis Solas, Anatoliy Kitaygorodskyy, et al.
Biology Direct|May 16, 2016
Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antiviralsSean Broce, Lisa Hensley, Tomoharu Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2013
Host-rabies virus protein-protein interactions as druggable antiviral targetsUsha F Lingappa, Xianfu Wu, Amanda Macieik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitorChao Zhang, Prabha N Ibrahim, Jiazhong Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|October 25, 2001
Enantiospecific Synthesis of (R)-4-Amino-5-oxo-1,3,4,5-tetrahydrobenz[cd]indole, an Advanced Intermediate Containing the Tricyclic Core of the ErgotsClarence R. Hurt, Ronghui Lin, Henry Rapoport
Current Pharmaceutical Biotechnology|March 21, 2012
Capsid assembly as a point of intervention for novel anti-viral therapeuticsVishwanath R Lingappa, Clarence R Hurt, Edward Garvey
Critical Reviews in Immunology|January 3, 2021
A Common Druggable Defect in Regulatory T Cells from Patients with AutoimmunityLuis Soares, Linda Yip, Clarence R Hurt, et al.
Molecular Diversity|March 4, 2009
Combinatorial chemistry: oh what a decade or two can doWalter H Moos, Clarence R Hurt, Guillermo A Morales
Journal of Virological Methods|June 15, 2013
Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitorsKevin B Spurgers, Clarence R Hurt, Jeffrey W Cohen, et al.
Frontiers in Immunology|December 26, 2022
How GRAIL controls Treg function to maintain self-toleranceC Garrison Fathman, Linda Yip, Diana Gómez-Martín, et al.
Journal of Virology|November 5, 2020
Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 AssemblyJonathan C Reed, Dennis Solas, Anatoliy Kitaygorodskyy, et al.
Biology Direct|May 16, 2016
Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antiviralsSean Broce, Lisa Hensley, Tomoharu Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2013
Host-rabies virus protein-protein interactions as druggable antiviral targetsUsha F Lingappa, Xianfu Wu, Amanda Macieik, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitorChao Zhang, Prabha N Ibrahim, Jiazhong Zhang, et al.
Pageof 1